Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.650
-0.010 (-0.60%)
At close: May 28, 2025, 4:00 PM
1.698
+0.048 (2.90%)
After-hours: May 28, 2025, 5:08 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $61.87 million as of May 28, 2025. Its market cap has decreased by -76.04% in one year.
Market Cap
61.87M
Enterprise Value
-119.48M
1-Year Change
-76.04%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $61.87M, a decrease of -89.01%. That is a compound annual growth rate of -81.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 62.05M | -54.07% |
| Dec 31, 2024 | 135.10M | -76.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.31B |
| Johnson & Johnson | 367.38B |
| AbbVie | 327.40B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 264.52B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |